Literature DB >> 24096009

Genome-wide association and sequencing studies on colorectal cancer.

Sunny H Wong1, Joseph J Y Sung, Francis K L Chan, Ka F To, Simon S M Ng, Xiao J Wang, Jun Yu, William K K Wu.   

Abstract

Colorectal cancer is a leading cause of morbidity and mortality worldwide. Understanding its genetic mechanisms is key to improving risk prediction, prognostication and treatment. Results from genome-wide association studies have engendered a growing list of colorectal cancer susceptibility genes whereas the application of genome-wide mutational analysis has enabled the depiction of mutational landscape of colorectal cancer at high resolution. The development of novel technologies, such as metagenomic and single-cell sequencing, is expected to have positive impact on future genetic studies. However, challenges remain to address the changing epidemiology of colorectal cancer, issues on genetic testing, and clinical utilization of genomic data.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; GWAS; Mutation; Next-generation sequencing

Mesh:

Year:  2013        PMID: 24096009     DOI: 10.1016/j.semcancer.2013.09.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  7 in total

1.  Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.

Authors:  Jun Yu; William K K Wu; Xiangchun Li; Jun He; Xiao-Xing Li; Simon S M Ng; Chang Yu; Zhibo Gao; Jie Yang; Miao Li; Qiaoxiu Wang; Qiaoyi Liang; Yi Pan; Joanna H Tong; Ka F To; Nathalie Wong; Ning Zhang; Jie Chen; Youyong Lu; Paul B S Lai; Francis K L Chan; Yingrui Li; Hsiang-Fu Kung; Huanming Yang; Jun Wang; Joseph J Y Sung
Journal:  Gut       Date:  2014-06-20       Impact factor: 23.059

Review 2.  Pathway and network approaches for identification of cancer signature markers from omics data.

Authors:  Jinlian Wang; Yiming Zuo; Yan-Gao Man; Itzhak Avital; Alexander Stojadinovic; Meng Liu; Xiaowei Yang; Rency S Varghese; Mahlet G Tadesse; Habtom W Ressom
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

3.  Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.

Authors:  Senwei Tang; William K K Wu; Xiangchun Li; Sunny H Wong; Nathalie Wong; Matthew T V Chan; Joseph J Y Sung; Jun Yu
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

4.  Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer.

Authors:  J Yu; W K K Wu; Q Liang; N Zhang; J He; X Li; X Zhang; L Xu; M T V Chan; S S M Ng; J J Y Sung
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

5.  miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.

Authors:  Hidekazu Hiramoto; Tomoki Muramatsu; Daisuke Ichikawa; Kousuke Tanimoto; Satoru Yasukawa; Eigo Otsuji; Johji Inazawa
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

6.  Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis.

Authors:  Xiaobo Zheng; Jinen Song; Chune Yu; Zongguang Zhou; Xiaowei Liu; Jing Yu; Guangchao Xu; Jiqiao Yang; Xiujing He; Xin Bai; Ya Luo; Yu Bao; Huifang Li; Lie Yang; Mingqing Xu; Nan Song; Xiaodong Su; Jie Xu; Xuelei Ma; Hubing Shi
Journal:  Signal Transduct Target Ther       Date:  2022-02-28

Review 7.  Advances in targeted and immunobased therapies for colorectal cancer in the genomic era.

Authors:  Heng Fong Seow; Wai Kien Yip; Theodora Fifis
Journal:  Onco Targets Ther       Date:  2016-03-31       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.